These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 20817457)

  • 1. Evaluation of commercial dysferlin antibodies on canine, mouse and human skeletal muscle.
    Guo LT; Moore SA; Forcales S; Engvall E; Shelton GD
    Neuromuscul Disord; 2010 Dec; 20(12):820-5. PubMed ID: 20817457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased dysferlin expression in Duchenne muscular dystrophy.
    Vontzalidis A; Terzis G; Manta P
    Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
    Piccolo F; Moore SA; Ford GC; Campbell KP
    Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective membrane repair in dysferlin-deficient muscular dystrophy.
    Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
    Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
    Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
    FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress.
    Ikezoe K; Furuya H; Ohyagi Y; Osoegawa M; Nishino I; Nonaka I; Kira J
    Acta Neuropathol; 2003 Jun; 105(6):603-9. PubMed ID: 12664320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
    Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
    FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
    Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
    Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysferlin and the plasma membrane repair in muscular dystrophy.
    Bansal D; Campbell KP
    Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
    Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
    Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of the dysferlin skeletal muscle promoter.
    Foxton RM; Laval SH; Bushby KM
    Eur J Hum Genet; 2004 Feb; 12(2):127-31. PubMed ID: 14560310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
    Inoue M; Wakayama Y; Kojima H; Shibuya S; Jimi T; Oniki H; Nishino I; Nonaka I
    Tohoku J Exp Med; 2006 Jun; 209(2):109-16. PubMed ID: 16707852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
    Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
    J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
    Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
    J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
    Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro dysferlin expression in human muscle satellite cells.
    De Luna N; Gallardo E; Illa I
    J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysferlin and muscular dystrophy.
    Bushby KM
    Acta Neurol Belg; 2000 Sep; 100(3):142-5. PubMed ID: 11098285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysferlin is a plasma membrane protein and is expressed early in human development.
    Anderson LV; Davison K; Moss JA; Young C; Cullen MJ; Walsh J; Johnson MA; Bashir R; Britton S; Keers S; Argov Z; Mahjneh I; Fougerousse F; Beckmann JS; Bushby KM
    Hum Mol Genet; 1999 May; 8(5):855-61. PubMed ID: 10196375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
    Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
    Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.